⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL63583 | 0.91 | — | — | |
| SCHEMBL17286403 | 0.81 | — | — | |
| Trifluoromethanesulfonic Acid SCHEMBL63721 | 0.78 | GPR3 (0.43) | — | |
| SCHEMBL8720547 | 0.72 | TSHR (0.32) | — | |
| SCHEMBL8720545 | 0.72 | — | — | |
| SCHEMBL21222692 | 0.67 | — | — | |
| SCHEMBL11890925 | 0.67 | — | — | |
| SCHEMBL17286589 | 0.60 | — | — | |
| Perchlorate SCHEMBL11802589 | 0.59 | POLB (0.40) | — | |
| SCHEMBL13075026 | 0.59 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 22 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025082616-A1 | ENERGY ADAPTER MODULE FOR A CELL | HELMHOLTZ-ZENTRUM FÜR UMWELTFORSCHUNG GMBH - UFZ (DE) | 2025-04-24 | — | — | WO | disclosed |
| US-20230272272-A1 | Surface Treatment Of Quantum Dots | UNITED STATES DEPARTMENT OF ENERGY | 2023-08-31 | — | — | US | disclosed |
| US-20190106414-A1 | SUBSTITUTED-INDOLE-COMPOUNDS AS ESTROGEN RECEPTOR DOWN-REGULATORS | Luoxin Healthcare Science and Technology Development (Beijing) Ltd. (CN) | 2019-04-11 | — | — | US | disclosed |
| WO-2017156265-A1 | DIRECT PALLADIUM-CATALYZED AROMATIC FLUORINATION | PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) | 2017-09-14 | — | — | WO | disclosed |
| EP-3114129-A1 | IMIDAZOPYRIDINE MACROCYCLES AS INHIBITORS OF HUMAN IMMUNODEFICIENCY VIRUS REPLICATION | VIIV Healthcare UK (No.5) Limited (GB) | 2017-01-11 | — | — | EP | disclosed |
| US-9409922-B2 | Imidazopyridine macrocycles as inhibitors of human immunodeficiency virus replication | BRISTOL-MYERS SQUIBB COMPANY (US) | 2016-08-09 | — | — | US | disclosed |
| WO-2015126751-A1 | IMIDAZOPYRIDINE MACROCYCLES AS INHIBITORS OF HUMAN IMMUNODEFICIENCY VIRUS REPLICATION | BRISTOL-MYERS SQUIBB COMPANY (US) | 2015-08-27 | — | — | WO | disclosed |
| US-20150232480-A1 | Imidazopyridine Macrocycles as Inhibitors of Human Immunodeficiency Virus Replication | VIIV HEALTHCARE UK (NO. 5) LIMITED (GB) | 2015-08-20 | — | — | US | disclosed |
| US-9061981-B2 | Diphenyl substituted cyclohexane derivatives, useful as modulators of the estrogen receptors beta | ACADIA PHARMACEUTICALS INC. (US) | 2015-06-23 | — | — | US | disclosed |
| US-20150034161-A1 | ORGANIC SEMICONDUCTING COMPOUNDS FOR USE IN ORGANIC ELECTRONIC DEVICES | NEXT ENERGY TECHNOLOGIES, INC. | 2015-02-05 | — | — | US | disclosed |
| EP-2554532-A1 | Diphenyl substituted cyclohexane derivatives, useful as modulators of the estrogen receptors beta | Acadia Pharmaceuticals Inc. (US) | 2013-02-06 | — | — | EP | disclosed |
| US-20120059179-A1 | PALLADIUM-CATALYZED ORTHO-FLUORINATION | The Scripps Research Insitiute (US) | 2012-03-08 | — | — | US | disclosed |
| US-20120059162-A1 | FUSED IMIDAZOLE DERIVATIVE HAVING TTK INHIBITORY ACTION | ONCOTHERAPY SCIENCE, INC. (JP) | 2012-03-08 | — | — | US | disclosed |
| US-8101651-B2 | Compounds with activity at estrogen receptors | ACADIA PHARMACEUTICALS INC. (US) | 2012-01-24 | — | — | US | disclosed |
| WO-2011013729-A1 | FUSED IMIDAZOLE DERIVATIVE HAVING TTK INHIBITORY ACTION | オンコセラピー・サイエンス株式会社 (JP) | 2011-02-03 | — | — | WO | disclosed |
| WO-2011006088-A2 | FLUORINE CONTAINING COMPOUNDS AND METHODS OF USE THEREOF | PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) | 2011-01-13 | — | — | WO | disclosed |
| US-20090131510-A1 | COMPOUNDS WITH ACTIVITY AT ESTROGEN RECEPTORS | ACADIA PHARMACEUTICALS INC. | 2009-05-21 | — | — | US | disclosed |
| WO-2009055734-A1 | CONDENSED COMPOUNDS WITH ACTIVITY AT ESTROGEN RECEPTORS | ACADIA PHARMACEUTICALS INC. (US) | 2009-04-30 | — | — | WO | disclosed |
| US-6174628-B1 | ELECTROLYTE HAS HIGH POLARITY, HIGH RESISTANCE TO OXIDATION AND FLAME RETARDANCE, AND THUS POSSESSES EXCELLENT CHARACTERISTICS AS THE ELECTROLYTE FOR ELECTRIC ENERGY GENERATORS | DAIKIN INDUSTRIES, LTD. (JP) | 2001-01-16 | — | — | US | disclosed |
| EP-0948073-A1 | ELECTROLYTIC SOLUTION AND DEVICE FOR GENERATING ELECTRIC ENERGY THEREWITH | Daikin Industries, Ltd. (JP) | 1999-10-06 | — | — | EP | disclosed |